Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.690
-0.010 (-0.21%)
Jun 26, 2026, 1:57 PM EDT - Market open
Lexeo Therapeutics Employees
Lexeo Therapeutics had 59 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
59
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,483,068
Market Cap
368.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 59 | 0 | - |
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Dec 31, 2023 | 58 | 34 | 141.67% |
| Dec 31, 2021 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| OmniAb | 89 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| X4 Pharmaceuticals | 45 |
LXEO News
- 1 day ago - Lexeo Therapeutics Transcript: AGM 2026 - Transcripts
- 1 day ago - Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan - TheFly
- 8 days ago - Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia - GlobeNewsWire
- 11 days ago - Lexeo Therapeutics Transcript: Investor update - Transcripts
- 11 days ago - Lexeo Therapeutics Slides: Investor update - Filings
- 11 days ago - Lexeo Therapeutics Press release: Investor update - Filings
- 11 days ago - Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan - TheFly
- 11 days ago - Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia - GlobeNewsWire